Genomic Screening of Healthy Individuals? Not Ready for Practice
New CDC blog post: When should we all have our genomes sequenced?
Reflections on the cost of "low-cost" whole genome sequencing: framing the health policy debate
Caulfield T, et al. PLoS Biol 11(11): e1001699 Nov 2013
Genomes of 100 000 people will be sequenced to create an open access research resource
Torjesen I BMJ 2013;347:f6690
It's really easy to get your genetic results. But good luck making sense of them,
by Sophie Novak, National Journal, Nov 8For $99 eliminating the mystery of the Pandora’s genetics box?
Clare Miller, The New York Times, Nov 11 Perspective
Reflections on the Cost of "Low-Cost" Whole Genome Sequencing: Framing the Health Policy Debate
- Published: Nov 05, 2013
- DOI: 10.1371/journal.pbio.1001699
Summary
The cost of whole genome sequencing is dropping rapidly. There has been a great deal of enthusiasm about the potential for this technological advance to transform clinical care. Given the interest and significant investment in genomics, this seems an ideal time to consider what the evidence tells us about potential benefits and harms, particularly in the context of health care policy. The scale and pace of adoption of this powerful new technology should be driven by clinical need, clinical evidence, and a commitment to put patients at the centre of health care policy.Citation: Caulfield T, Evans J, McGuire A, McCabe C, Bubela T, et al. (2013) Reflections on the Cost of "Low-Cost" Whole Genome Sequencing: Framing the Health Policy Debate. PLoS Biol 11(11): e1001699. doi:10.1371/journal.pbio.1001699
Published: November 5, 2013
Copyright: © 2013 Caulfield et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: All of the funding agencies provided support for the workshop, including the cost of flights and accommodations. Primary funding support was provided by: CIHR Institute of Genetics (http://www.cihr-irsc.gc.ca/e/193.html), Genome Canada (http://www.genomecanada.ca), X PRIZE Foundation, ACOA Atlantic Innovation Fund (http://www.acoa-apeca.gc.ca/eng/ImLookingFor/ProgramInformation/AtlanticInnovationFund/Pages/AtlanticInnovationFund.aspx), and the University of Toronto/McLaughlin Centre. Additional funding by the Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (221S0002), Japan (K.K.), the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, NIH (BB), and the Marion Ewing Kauffman Foundation, National Human Genome Research Institute, NIH (P50 HG003391) (RCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this paper do not reflect the views of funders.
Competing interests: The authors have declared that no competing interests exist.
Published: November 5, 2013
Copyright: © 2013 Caulfield et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: All of the funding agencies provided support for the workshop, including the cost of flights and accommodations. Primary funding support was provided by: CIHR Institute of Genetics (http://www.cihr-irsc.gc.ca/e/193.html), Genome Canada (http://www.genomecanada.ca), X PRIZE Foundation, ACOA Atlantic Innovation Fund (http://www.acoa-apeca.gc.ca/eng/ImLookingFor/ProgramInformation/AtlanticInnovationFund/Pages/AtlanticInnovationFund.aspx), and the University of Toronto/McLaughlin Centre. Additional funding by the Grant-in-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) (221S0002), Japan (K.K.), the Intramural Research Program of the National Human Genome Research Institute, National Institutes of Health, NIH (BB), and the Marion Ewing Kauffman Foundation, National Human Genome Research Institute, NIH (P50 HG003391) (RCD). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The views expressed in this paper do not reflect the views of funders.
Competing interests: The authors have declared that no competing interests exist.
.png)
No hay comentarios:
Publicar un comentario